Nanoparticle Epirubicin Uses, Dosage, Side Effects and more
Nanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma).
| Trade Name | Nanoparticle Epirubicin |
| Generic | Nanoparticle Epirubicin |
| Nanoparticle Epirubicin Other Names | Micellar nanoparticle-encapsulated epirubicin, Nanoparticle epirubicin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
